Search the Newsroom
Filter By
Showing 891 - 900 of 3044 results
Feature Article: Does My Child Benefit from a COVID-19 Vaccine?
In this issue of Parents PACK, we take a closer look at COVID-19 and kids, including disease complications, immunity after natural infection, vaccination rates, and safety of the COVID-19 vaccine.
Vaccine News & Notes — March 2023
Check out a new infographic highlighting three important points related to aluminum in vaccines, and find links to the updated 2023 immunization schedules.
Dr. Handy’s Corner: Do Vaccines Weaken My Baby’s Immune System?
See why Dr. Lori Handy views vaccines as strengthening the immune system instead of weakening it.
How Vision Can Support or Delay Learning in a Child with Down Syndrome: Part 3
Once an individual collects visual input from their environment, they must organize, interpret, evaluate this information to make decisions about how to interact with their environment.
Individualized Ventilator Support in Treatment for Pulmonary Hypoplasia
A range of different noninvasive mechanical ventilation supports helped this patient with pulmonary hypoplasia avoid tracheostomy.
CHOP Partners With Ethiopian Family to Spread Down Syndrome Awareness
CHOP’s Trisomy 21 team partners with patient family and the Deborah Foundation to spread awareness and education about Down syndrome to Ethiopia.
Toilet Training Children and Adolescents with Down Syndrome
Toilet training for children and adolescents with Down syndrome may take longer to learn because of a variety of tasks that need to be mastered and coordinated to successfully void on the toilet.
CHOP Urologists Lead 15 Years of Global Care at The U.S.-India Bladder Exstrophy Collaborative
Every year, surgeons, anesthesiologists, social workers, and other healthcare providers from hospitals across the world gather with a common goal: to bring expert care to patients who travel from near and far seeking hope.
CHOP Selected As New Center for Turning Research Results Into Clinical Practice
CHOP is one of 42 institutions selected by the Patient-Centered Outcomes Research Institute (PCORI) as part of the $50 million initiative.
FDA Approves First Drug for Friedreich’s Ataxia
The drug, omaveloxolone, is a once-a-day pill that will help improve neurological function and slow progression of the neurodegenerative disease.